Picture of Consun Pharmaceutical logo

1681 Consun Pharmaceutical Share Price

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousMid CapSuper Stock

Momentum

Relative Strength (%)
1m+6.58%
3m+7.84%
6m+4.35%
1yr+13.25%
Volume Change (%)
10d/3m+57.36%
Price vs... (%)
52w High-12.85%
50d MA+4.74%
200d MA+10.31%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)4.57
PEG Ratio (f)0.39
EPS Growth (f)13.33%
Dividend Yield (f)8.87%
Valuation (ttm)IndustryMarket
Price to Book Value1.24
Price to Tang. Book1.33
Price to Free Cashflow5.97
Price to Sales1.67
EV to EBITDA1.82

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital23.09%
Return on Equity23.91%
Operating Margin34.59%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueCNYm1,728.261,752.832,044.662,339.652,590.112,9203,3167.03%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-48.59+122.96+20.46+17.43+13.78+8.89+14.95n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Consun Pharmaceutical EPS forecast chart

Profile Summary

Consun Pharmaceutical Group Ltd is a company principally engaged in manufacturing and sales of pharmaceutical products. The Company operates its businesses through two segments. Consun Pharmaceutical segment is mainly engaged in manufacturing and sells of modern Chinese medicines and medical contrast medium. Yulin Pharmaceutical segment is mainly involved in manufacturing and sells of traditional Chinese medicines. The Company's products include kidney medicines, gynaecology and paediatrics medicines, contrast medium, orthopedics medicines, dermatologic medicines, hepatobiliary medicines and others. The Company mainly operates its businesses in the domestic market.

Directors

Last Annual
December 31st, 2023
Last Interim
June 30th, 2024
Incorporated
December 13th, 2010
Public Since
December 19th, 2013
No. of Employees
3,178
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
hk flag iconStock Exchange of Hong Kong Limited
Shares in Issue
844,889,255

1681 Share Price Performance

Upcoming Events for 1681

Similar to 1681

Picture of 3D Medicines logo

3D Medicines

hk flag iconStock Exchange of Hong Kong Limited

Picture of 3SBio logo

3SBio

hk flag iconStock Exchange of Hong Kong Limited

Picture of AIM Vaccine Co logo

AIM Vaccine Co

hk flag iconStock Exchange of Hong Kong Limited

Picture of Ascletis Pharma logo

Ascletis Pharma

hk flag iconStock Exchange of Hong Kong Limited

Picture of Asymchem Laboratories Tianjin Co logo

Asymchem Laboratories Tianjin Co

hk flag iconStock Exchange of Hong Kong Limited

FAQ